[1]
E. Van Den Dorpe, H. Van Roeyen, and V. Labarque, “Efficacy and Safety of Therapeutic Options in Children and Adolescents With Persistent or Chronic Primary Immune Thrombocytopenia: A Systematic Review”, Belg J Paediatr, vol. 28, no. 3, pp. 263–292, Oct. 2026.